Activateur en T humain CD3/CD28 Dynabeads™ pour l’expansion et l’activation des cellules T
Activateur en T humain CD3/CD28 Dynabeads™ pour l’expansion et l’activation des cellules T
Gibco™

Activateur en T humain CD3/CD28 Dynabeads™ pour l’expansion et l’activation des cellules T

Les microbilles d’activateur T humain Dynabeads™ CD3 / CD28 sont destinées à l’activation et à l’expansion des cellules T humaines.AvantagesAfficher plus
Have Questions?
Modifier l'affichagebuttonViewtableView
RéférenceVolume (métrique)
11131D2 ml
11161D0,4 ml
11132D5 x 2 ml
Référence 11131D
Prix (EUR)
689,60
Special offer
Online exclusive
termine: 06-Feb-2026
900,00
Économisez 210,40 (23%)
Each
Ajouter au panier
Volume (métrique):
2 ml
Prix (EUR)
689,60
Special offer
Online exclusive
termine: 06-Feb-2026
900,00
Économisez 210,40 (23%)
Each
Ajouter au panier
Les microbilles d’activateur T humain Dynabeads™ CD3 / CD28 sont destinées à l’activation et à l’expansion des cellules T humaines.

Avantages des microbilles d’activateur T humain Dynabeads CD3 / CD28 :

• Activation des cellules T sans besoin de cellules nourricières
• Cellules activées qui conservent une fonction comparable à la fonction in vivo
• Reproductibilité maximale sans contamination par des anticorps ou des mitogènes solubles
• Expansion des cellules T de 100 à 1 000 fois

À propos des micobilles d’activateur de cellules T humaines Dynabeads™ CD3 / CD28 :
Les microbilles d’activateur de cellules T humaines Dynabeads™ CD3 / CD28 offrent une méthode simple pour l’activation et l’expansion des cellules T qui ne nécessitent pas de cellules nourricières (cellules présentant des antigènes) ou d’antigène. Les microbilles uniformes de 4,5 µm de diamètre, inertes et superparamagnétiques ont une dimension similaire à celle des cellules présentant des antigènes et sont couplées par covalence aux anticorps anti-CD3 et anti-CD28. Ces deux anticorps émettent des signaux primaires et co-stimulateurs, optimisés pour l’activation et l’expansion efficaces des cellules T. L’expansion de la population de cellules T peut être stimulée à l’aide du recombinant IL-2 et, après activation ou expansion, les microbilles magnétiques peuvent facilement être éliminées à l’aide d’un aimant DynaMag™. Pour l’expansion de cellules T spécifiques aux antigènes à partir de clones de cellules T ou de lignées cellulaires T, nous recommandons d’utiliser l’activateur cellules T humaines Dynabeads™ CD3 / CD28/CD137.

Échantillons de départ
Commencer par des cellules mononucléées (MNC) / des cellules mononucléées de sang périphérique (PBMC) provenant de sous-ensembles de sang total ou de couche tampon, ou de cellules T, y compris les cellules T CD3+, les cellules T CD4+ ou CD8+, ou les cellules T régulatrices.

Applications en aval
Les cellules T activées peuvent être analysées peu de temps après l’activation (pour transfection / transduction ou pour étudier la signalisation des TCR, la protéomique, l’expression génétique, etc.). Les cellules T peuvent être laissées dans la culture pour se différencier en sous-ensembles de cellules T auxiliaires ou pour l’expansion de cellules T spécifiques au polyclonage / aux antigènes.

En savoir plus sur les produits Dynabeads™
• Découvrez les des produits Dynabeads™ pour une gamme complète d’applications.
• Trouvez des aimants pour les séparations Dynabeads™.
Usage exclusivement réservé à la recherche. Ne pas utiliser pour des procédures de diagnostic.
Spécifications
Type de celluleCellules T (population entière)
Certifications/ConformitéISO9001 and ISO13485
ClonalitéMonoclonal
Concentration4 x 10 7 Beads/mL
DescriptionMonoclonal anti-human CD3 and CD28 antibodies covalently bound to DynaBeads magnetic Beads
Type de produit finalCellules
À utiliser avec (équipement)DynaMag™ Magnet
Espèces hôtesSouris
Technologie d’isolementMagnetic Beads
Gamme de produitsDYNAL, Dynabeads
Quantité2 ml
RéactivitéHumaine
État réglementaireFor Research Use Only
Type d’échantillonCultures cellulaires, PBMC
Durée de conservation24 mois à compter de la date de fabrication
Conditions d’expéditionTempérature ambiante
Fonctionnalité de surfaceÉpoxy
Espèces ciblesHumaine
UniformitéMonosized 4.5 μm (CV <5%)
Volume (métrique)2 ml
CouleurBrown
Diamètre (métrique)4,5 μm
À utiliser avec (application)Activation and Expansion of T-cells
MatériauPolystyrène magnétique
Type de produitActivateur T humain CD3 / CD28
Unit SizeEach
Contenu et stockage
L’activateur de cellules T humaines CD3 / CD28 Dynabeads™ Human T-Activator CD3 / CD28 est fourni sous forme de suspension contenant 4 × 107 de Dynabeads™ / ml dans une solution saline tamponnée au phosphate (PBS), pH 7,4, avec 0,1 % d’albumine sérique humaine (HSA).

Conditions de conservation : 2°C à 8°C. Ne pas congeler.

Foire aux questions (FAQ)

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Citations et références (4)

Citations et références
Abstract
Dasatinib, a small molecule protein tyrosine kinase inhibitor, inhibits T cell activation and proliferation.
Authors:Schade AE, Schieven GL, Townsend R, Jankowska AM, Susulic V, Zhang R, Szpurka H, Maciejewski JP,
Journal:Blood
PubMed ID:17962511
'Dasatinib is an oral small molecule inhibitor of Abl and Src family tyrosine kinases (SFK), including p56(Lck) (Lck). Given the central importance of Lck in transmitting signals from the T cell receptor (TCR) signaling complex, and the potent ability of dasatinib to inhibit Lck activity, we hypothesized this agent could ... More
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.
Authors:Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, Civeira MP, Heeney JL, Rollier C, Verstrepen B, Wakita T, Borrás-Cuesta F, Lasarte JJ, Prieto J,
Journal:J Virol
PubMed ID:17229698
Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan ratio (a reflection of IDO activity). Huh7 cells supporting hepatitis ... More
Activated human CD4+ T cells express transporters for both cysteine and cystine.
Authors:Levring TB, Hansen AK, Nielsen BL, Kongsbak M, von Essen MR, Woetmann A, Odum N, Bonefeld CM, Geisler C,
Journal:Sci Rep
PubMed ID:22355778
Because naïve T cells are unable to import cystine due to the absence of cystine transporters, it has been suggested that T cell activation is dependent on cysteine generated by antigen presenting cells. The aim of this study was to determine at which phases during T cell activation exogenous cystine/cysteine ... More
Loss of Siglec expression on T lymphocytes during human evolution.
Authors:Nguyen DH, Hurtado-Ziola N, Gagneux P, Varki A
Journal:Proc Natl Acad Sci U S A
PubMed ID:16682635
We report here that human T cells give much stronger proliferative responses to specific activation via the T cell receptor (TCR) than those from chimpanzees, our closest evolutionary relatives. Nonspecific activation using phytohemagglutinin was robust in chimpanzee T cells, indicating that the much lower response to TCR simulation is not ... More